Le Lézard
Classified in: Science and technology, Business
Subject: LIC

Roqos Provides Private SASE Solution to Big City Municipality


Roqos has entered into an agreement with a large city municipality to deliver a Private SASE based cybersecurity and networking solution which involves 32 locations connected to the headquarters via Roqos's patented OmniVPN® technology.

RESTON, Va., March 8, 2024 /PRNewswire-PRWeb/ -- Roqos, the innovative leader in cybersecurity solutions, has entered into an agreement with a large city municipality to deliver a SASE-based cybersecurity and networking solution. The setup involves 32 locations, each equipped with a Roqos Core appliance connected to the headquarters via Roqos's patented OmniVPN® technology over the internet. By leveraging Roqos Cores' SD-WAN features, the city has eliminated the need for expensive MPLS links and implemented a private cloud-managed SASE and ZTNA solution that supports hundreds of users with various roles, geolocations and work schedules.

Roqos is providing a comprehensive cybersecurity and networking solution with its innovative Private SASE to a major city municipality.

 

"We are delighted to receive this strong endorsement of our Private SASE solution. Not all customers are comfortable using public SASE due to technical reasons, risks, or regulations, especially government institutions. This large-scale implementation of Roqos Private SASE is further proof of Roqos's innovative approach to networking and cybersecurity," said Sezen Uysal, founder and CEO of Roqos. "Our customers' requirements and challenges are always key inputs to our design process. Instead of just adhering strictly to what's trendy or popular, or pushing for forklift upgrades, we offer innovative, powerful, and secure networking solutions that can be seamlessly integrated into our customers' existing infrastructures."

As an embodiment of the popular distributed Roqos SASE solution, Roqos's Private SASE solution offers a full suite of SASE, ZTNA, and SD-WAN features with cloud management and direct data connections among Roqos Core appliances using OmniVPN®, all while being fully implemented in the customer's data centers. Visit Roqos SASE , Roqos ZTNA and OmniVPN® to learn more.

About Roqos

Founded in 2014 and based in Reston, VA, Roqos, Inc. provides innovative cybersecurity and networking solutions through its high-performance Roqos Cores appliances, Roqos Cloud, and Roqos SASE applications for phones and laptops. For more information, visit the Roqos website at roqos.com or their LinkedIn page https://www.linkedin.com/company/roqos-inc-.

Media Contact

Marketing, Roqos, 1 571.323.1500, [email protected], roqos.com

SOURCE Roqos


These press releases may also interest you

at 08:20
Merck , known as MSD outside of the United States and Canada, and Orion Corporation ("Orion") today announced that notice has been provided of the mutual exercise of an option to convert the companies' ongoing co-development and co-commercialization...

at 08:20
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, filed a lawsuit asserting multiple claims for damages against Exact Sciences on June 28, 2024, in federal court in the...

at 08:17
After rocketing to success across social media, boohoo announced The boohoo Collective; an initiative redefining social commerce by integrating 1000s of creators into the shopping experience on boohoo.com. The initiative gives any creator a personal...

at 08:15
Masimo Corporation ("Masimo" or the "Company") today issued a letter to stockholders in connection with the Company's 2024 Annual Meeting of Stockholders. The letter highlights the fierce independence and deep medtech experience of nominee...

at 08:15
Following the CEO transition plan previously announced by Bentley Systems, Incorporated , Nicholas Cumins today takes charge as CEO. Cumins succeeds Greg Bentley, the eldest of the five brothers who founded Bentley Systems, who becomes Executive...

at 08:15
KaliVir Immunotherapeutics, Inc., a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced that the FDA has cleared the Investigational New Drug (IND) application for the STEALTH-001 study...



News published on and distributed by: